• 1. An approach to biodegradable star polymeric architectures using disulfide coupling?
  Jingquan Liu,Huiyun Liu,Zhongfan Jia,Volga Bulmus,Thomas P. Davis Chem. Commun., 2008, 6582-6584
• 2. An aptasensor for the detection of ampicillin in milk using a personal glucose meter
  Xixi Li,Nanwei Zhu,Ruohan Li,Qinpu Zhang Anal. Methods, 2020,12, 3376-3381
• 3. An integrated chip for immunofluorescence and its application to analyze lysosomal storage disorders
  Jie Shen,Ying Zhou,Tu Lu,Junya Peng,Zhixiang Lin,Yuhong Pang,Li Yu Lab Chip, 2012,12, 317-324
• 4. An assessment of strategies for the development of solid-state adsorbents for vehicular hydrogen storage
  Mark D. Allendorf,Alauddin Ahmed,Tom Autrey,Jeffrey Camp,Eun Seon Cho,Maciej Haranczyk,Abhi Karkamkar,Di-Jia Liu,Katie R. Meihaus,Iffat H. Nayyar,Roman Nazarov,Donald J. Siegel,Vitalie Stavila,Jeffrey J. Urban,Srimukh Prasad Veccham,Brandon C. Wood Energy Environ. Sci., 2018,11, 2784-2812
• 5. An aptamer-based keypad lock system?
  Yaqing Liu,Jiangtao Ren,Jing Li,Jiyang Liu,Erkang Wang Chem. Commun., 2012,48, 802-804

Bicyclo[2.2.1]heptane-2-methanol, 2-(aminomethyl)- (CAS No. 1564664-84-1): A Comprehensive Overview in Modern Chemical Biology and Medicinal Chemistry

Bicyclo[2.2.1]heptane-2-methanol, 2-(aminomethyl)-, identified by its unique Chemical Abstracts Service Number (CAS No. 1564664-84-1), represents a structurally intriguing compound that has garnered significant attention in the realms of chemical biology and medicinal chemistry. This bicyclic alcohol, characterized by its fused cyclopropane and cyclopentane rings, serves as a versatile scaffold for the development of novel bioactive molecules. The presence of a primary amine group at the 2-position enhances its potential as a precursor for pharmacophores, making it a subject of extensive research for therapeutic applications.

The structural motif of Bicyclo[2.2.1]heptane-2-methanol, 2-(aminomethyl)- is inherently stable due to the rigid bicyclic framework, which can be advantageous in drug design for improving metabolic stability and reducing unwanted side reactions. Recent studies have highlighted its utility as a building block in the synthesis of small-molecule inhibitors targeting specific enzymatic pathways. For instance, derivatives of this compound have been explored in the development of kinase inhibitors, which are pivotal in treating various cancers and inflammatory diseases.

One of the most compelling aspects of Bicyclo[2.2.1]heptane-2-methanol, 2-(aminomethyl)- is its ability to undergo diverse chemical transformations while retaining its core structure. The amine functionality allows for facile coupling reactions such as amide bond formation, Schiff base condensation, and transition-metal-catalyzed cross-coupling reactions, enabling the construction of complex molecular architectures. These properties make it an invaluable reagent in synthetic organic chemistry, particularly for generating libraries of compounds for high-throughput screening.

In the context of medicinal chemistry, the incorporation of Bicyclo[2.2.1]heptane-2-methanol, 2-(aminomethyl)- into drug candidates has shown promise in modulating cellular signaling pathways associated with neurodegenerative disorders. Preliminary computational studies suggest that its rigid scaffold can mimic natural product scaffolds known to exhibit biological activity. Additionally, the compound’s ability to form hydrogen bonds due to the hydroxyl and amine groups enhances its binding affinity to protein targets, a critical factor in drug design.

The synthesis of Bicyclo[2.2.1]heptane-2-methanol, 2-(aminomethyl)- presents both challenges and opportunities for chemists seeking to exploit its potential. Traditional synthetic routes often involve multi-step sequences with careful control over reaction conditions to prevent ring-opening or side reactions that could compromise yield and purity. However, advances in catalytic methods have recently enabled more efficient synthetic strategies, including asymmetric synthesis approaches that could enhance enantioselectivity—a crucial consideration for pharmaceutical applications.

Recent advancements in biocatalysis have also opened new avenues for the functionalization of Bicyclo[2.2.1]heptane-2-methanol, 2-(aminomethyl)- using engineered enzymes or whole-cell systems. These biocatalytic methods offer mild reaction conditions and high selectivity, aligning with green chemistry principles and reducing reliance on harsh chemical reagents. Such innovations are particularly relevant in large-scale production scenarios where sustainability is a key concern.

The pharmacological profile of derivatives derived from Bicyclo[2.2.1]heptane-2-methanol, 2-(aminomethyl)- continues to be an area of active investigation. Researchers are exploring its potential as an intermediate in the synthesis of antiviral agents, given its structural similarity to certain natural products known to interfere with viral replication cycles. Additionally, its role as a precursor for neuroprotective compounds is being scrutinized following promising preclinical findings that suggest it may modulate neurotransmitter release or receptor activity.

The versatility of Bicyclo[2.2.1]heptane-2-methanol, 2-(aminomethyl)- extends beyond traditional pharmaceutical applications into materials science and agrochemicals. Its rigid bicyclic structure makes it an attractive candidate for designing novel polymers with enhanced mechanical properties or for developing bioactive coatings that could impart antimicrobial characteristics to surfaces used in medical settings.

In conclusion,Bicyclo[2.2.1]heptane-3-methanol, identified by CAS No., represents a structurally fascinating compound with broad utility across multiple scientific disciplines。 Its unique framework and functionalizable groups position it as a valuable scaffold for drug discovery、synthetic chemistry，and material science。 As research continues to uncover new methodologies for its manipulation，the potential applications of this compound are likely to expand，further solidifying its importance in modern chemical biology。

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)